跳至主要内容
临床试验/NCT01633008
NCT01633008已完成早期 1 期

Acceptance and Commitment Therapy for Adolescents and Adults With Neurofibromatosis Type 1 and Chronic Pain: A Pilot Study

National Cancer Institute (NCI)2 个研究点 分布在 1 个国家目标入组 28 人开始时间: 2012年6月15日最近更新:
适应症
干预措施

试验速览

阶段
早期 1 期
状态
已完成
入组人数
28
试验地点
2
主要终点
Pain improvement

研究概览

简要总结

Background:

  • Neurofibromatosis type 1 (NF1) is a genetic disorder that can cause frequent and significant pain. This pain can have a severe impact on a person s quality of life.
  • Acceptance and Commitment Therapy (ACT) is a new type of therapy that may help people manage pain. It teaches behavioral techniques that can be used to change how people react to pain. ACT may help people with NF1 cope better with the pain associated with the disorder. Researchers want to test ACT techniques to see if they can improve coping in people with NF1 pain.

Objectives:

  • To see if ACT can help treat chronic pain in adolescents and young adults who have NF1.

Eligibility:

  • Adolescents and young adults between 12 and 21 years of age who have chronic pain associated with NF1.

Design:

  • Participants will be screened with a physical exam and medical history. They will also complete a set of questionnaires about their pain levels, quality of life, and medications that they are taking.
  • Participants will take part in a training workshop for ACT. It will consist of three 2-hour sessions over 2 consecutive days. The workshop will teach techniques for setting goals that reflect personal values, and changing the focus from pain avoidance to pain management. There will be practice exercises between each session.
  • At the end of the workshop, participants will receive a workbook with the exercises to continue to practice at home. Participants will be encouraged to spend at least 20 minutes, three times per week, on these practice exercises.
  • There will be a followup phone call to check on pain management after the workshop.
  • Three months after the first study visit, participants will complete the study questionnaires again from home. They will provide more information about how they are managing their pain. The questionnaires will be returned by mail in an envelope provided by the study team.

详细描述

Background:

  • Neurofibromatosis type 1 (NF1) is a genetic disorder that affects approximately 1 in 3,500 individuals.

  • A number of common clinical manifestations, including plexiform neurofibromas, scoliosis, and chronic headaches, can cause frequent and significant pain and impact quality of life.

  • Often, NF1-related pain is not well-controlled with medication and many of the medications cause significant side effects.

  • To our knowledge, no studies have examined the effectiveness of behavioral interventions for chronic pain in individuals with NF1.

  • Acceptance and Commitment Therapy (ACT), a newer generation of cognitive-behavioral therapy, focuses on encouraging individuals to engage in more adaptive ways of coping with pain or distress.

  • In helping individuals with pain, the goal of ACT is not to eliminate the person s pain, but to optimize the person s quality of life despite their pain.

Objectives:

  • To evaluate whether the Acceptance and Commitment Therapy (ACT) group demonstrates improvement on the Modified Brief Pain Inventory scale from baseline to 3 months in adolescents and young adults with NF1 and chronic pain.
  • To examine changes in patient s functional ability, quality of life, pain-related coping, pain-related anxiety, pain severity, and depression from baseline to 3 months
  • To examine the effects of ACT on parents psychological well-being, overall stress, and ability to cope with their child s pain
  • To explore the relationship between changes in patients pain interference, functional ability, pain-related coping, pain-related anxiety, pain severity, depression and treatment adherence with demographic variables, parent stress, and parent coping
  • To collect preliminary data on the value of ACT to guide the potential development of a future phase II trial

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
12 Years 至 99 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究组 & 干预措施

1

Experimental

Attend three 2-hour sessions held over two consecutive days

干预措施: ACT Workshop (Behavioral)

结局指标

主要结局

Pain improvement

时间窗: 3 months

次要结局

  • Value of the ACT for future Ph2 trial.(6 months)
  • Psychological well-being & stress changes in parents(3 months)
  • Explore improvements of pain interference, abilities, coping, anxiety,depression, etc(3 months)
  • Relationship between pain and treatment adherence(3 months)

研究者

申办方类型
Nih
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验